Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Michael Sand gives the reader an overview of current techniques in expression profiling of miRNAs and their maturation machinery in the skin. This book is a postdoctoral thesis on miRNAs in cutaneous malignant melanoma and non-melanoma skin cancer with a focus on the miRNA processing machinery and miRNA expression profiling. The research presented in this book was performed in the Dermatologic Surgery Section at the Department of Dermatology, Venereology and Allergology of the Ruhr-University Bochum, Germany and gives the reader an overview of current techniques in expression profiling of miRNAs and their maturation machinery in the skin.…mehr
Michael Sand gives the reader an overview of current techniques in expression profiling of miRNAs and their maturation machinery in the skin. This book is a postdoctoral thesis on miRNAs in cutaneous malignant melanoma and non-melanoma skin cancer with a focus on the miRNA processing machinery and miRNA expression profiling. The research presented in this book was performed in the Dermatologic Surgery Section at the Department of Dermatology, Venereology and Allergology of the Ruhr-University Bochum, Germany and gives the reader an overview of current techniques in expression profiling of miRNAs and their maturation machinery in the skin.
Michael Sand, MD studied medicine at the Ruhr-University of Bochum / Germany, Harvard Medical School Boston and the University of California, San Diego (UCSD). After board certification in Dermatology, Venereology and Emergency Medicine at the Ruhr-University Bochum / Germany he and his team started to investigate the role of microRNA in the skin. He is currently an attending physician in the Department of Plastic Surgery, Catholic Clinics of the Ruhr Peninsula, Essen, Germany with a clinical focus on surgical therapy of skin cancer and a research focus on the role of microRNAs in malignant skin tumors.
Inhaltsangabe
Introduction.- Objectives of this work.- Summary and discussion of this work.- Closing remarks.- Paper 1: Expression levels of the microRNA processing enzymes Drosha and Dicer in epithelial skin cancer.- Paper 2: Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA- induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1 and TARBP2 in epithelial skin cancer.- Paper 3: Expression of microRNAs in basal cell carcinoma.- Paper 4: Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.- Paper 5: The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi.- Paper 6: Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi.- Paper 7: Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi.- Paper 8: MicroRNAs and the skin: tiny players in the body’s largest organ.- Paper 9: microRNA in non-melanoma skin cancer.
Introduction.- Objectives of this work.- Summary and discussion of this work.- Closing remarks.- Paper 1: Expression levels of the microRNA processing enzymes Drosha and Dicer in epithelial skin cancer.- Paper 2: Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA- induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1 and TARBP2 in epithelial skin cancer.- Paper 3: Expression of microRNAs in basal cell carcinoma.- Paper 4: Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.- Paper 5: The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi.- Paper 6: Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi.- Paper 7: Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi.- Paper 8: MicroRNAs and the skin: tiny players in the body's largest organ.- Paper 9: microRNA in non-melanoma skin cancer.
Introduction.- Objectives of this work.- Summary and discussion of this work.- Closing remarks.- Paper 1: Expression levels of the microRNA processing enzymes Drosha and Dicer in epithelial skin cancer.- Paper 2: Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA- induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1 and TARBP2 in epithelial skin cancer.- Paper 3: Expression of microRNAs in basal cell carcinoma.- Paper 4: Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.- Paper 5: The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi.- Paper 6: Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi.- Paper 7: Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi.- Paper 8: MicroRNAs and the skin: tiny players in the body’s largest organ.- Paper 9: microRNA in non-melanoma skin cancer.
Introduction.- Objectives of this work.- Summary and discussion of this work.- Closing remarks.- Paper 1: Expression levels of the microRNA processing enzymes Drosha and Dicer in epithelial skin cancer.- Paper 2: Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA- induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1 and TARBP2 in epithelial skin cancer.- Paper 3: Expression of microRNAs in basal cell carcinoma.- Paper 4: Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.- Paper 5: The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi.- Paper 6: Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi.- Paper 7: Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi.- Paper 8: MicroRNAs and the skin: tiny players in the body's largest organ.- Paper 9: microRNA in non-melanoma skin cancer.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/neu
